Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Antibodies to protein but not glycolipid structures are important for host defense against Mycoplasma pneumoniae.

Meyer Sauteur PM, de Bruijn ACJM, Graça C, Tio-Gillen AP, Estevão SC, Hoogenboezem T, Hendriks RW, Berger C, Jacobs BC, van Rossum AMC, Huizinga R, Unger WWJ.

Infect Immun. 2018 Nov 5. pii: IAI.00663-18. doi: 10.1128/IAI.00663-18. [Epub ahead of print]

PMID:
30396892
2.

Reply to: Comment on: Zika virus and Guillain-Barré syndrome in Bangladesh.

GeurtsvanKessel CH, Islam Z, Jacobs BC, Endtz HP.

Ann Clin Transl Neurol. 2018 Jul 13;5(9):1140-1141. doi: 10.1002/acn3.619. eCollection 2018 Sep. No abstract available.

3.

Regional variation of Guillain-Barré syndrome.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium .

Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232.

PMID:
30247567
4.

[Bell's palsy: different doctor, different care?]

Buizert A, Verboon JC, Wirtz PW, Koopman JP, van Roosmalen RM, Jacobs BC, de Bruijn SFTM.

Ned Tijdschr Geneeskd. 2018 Aug 16;162. pii: D2370. Dutch.

PMID:
30211994
5.

Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.

Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA; Dutch GBS Study Group.

J Peripher Nerv Syst. 2018 Aug 27. doi: 10.1111/jns.12286. [Epub ahead of print]

PMID:
30151941
6.

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study.

Islam B, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD.

BMJ Open. 2018 Aug 17;8(8):e022862. doi: 10.1136/bmjopen-2018-022862.

7.

Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.

Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, Jacobs BC.

J Peripher Nerv Syst. 2018 Aug 12. doi: 10.1111/jns.12285. [Epub ahead of print]

PMID:
30101437
8.

Advances in management of Guillain-Barré syndrome.

Doets AY, Jacobs BC, van Doorn PA.

Curr Opin Neurol. 2018 Oct;31(5):541-550. doi: 10.1097/WCO.0000000000000602.

PMID:
30074496
9.

Reply to: "Association of hepatitis E virus infection and myasthenia gravis: A pilot study".

van Eijk JJJ, Cintas P, Jacobs BC, Kamar N, Dalton HR.

J Hepatol. 2018 Jun;68(6):1321-1322. doi: 10.1016/j.jhep.2018.02.017. No abstract available.

PMID:
29776554
10.

Zika virus and Guillain-Barré syndrome in Bangladesh.

GeurtsvanKessel CH, Islam Z, Islam MB, Kamga S, Papri N, van de Vijver DAMC, Reusken C, Mogling R, Heikema AP, Jahan I, Pradel FK, Pavlicek RL, Mohammad QD, Koopmans MPG, Jacobs BC, Endtz HP.

Ann Clin Transl Neurol. 2018 Apr 6;5(5):606-615. doi: 10.1002/acn3.556. eCollection 2018 May.

11.

Clinical outcome of Guillain-Barré syndrome after prolonged mechanical ventilation.

van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):949-954. doi: 10.1136/jnnp-2018-317968. Epub 2018 Apr 7.

PMID:
29627773
12.

Zika virus infection in the returning traveller: what every neurologist should know.

Leonhard SE, Lant S, Jacobs BC, Wilder-Smith A, Ferreira MLB, Solomon T, Willison HJ.

Pract Neurol. 2018 Aug;18(4):271-277. doi: 10.1136/practneurol-2017-001789. Epub 2018 Apr 4. Review.

13.

Guillain-Barré syndrome following varicella-zoster virus infection.

Islam B, Islam Z, GeurtsvanKessel CH, Jahan I, Endtz HP, Mohammad QD, Jacobs BC.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):511-518. doi: 10.1007/s10096-018-3199-5. Epub 2018 Feb 6.

PMID:
29411189
14.

Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Drenthen J, Unger WWJ, Jacobs E, van Rossum AMC, Jacobs BC.

J Neuroimmunol. 2018 Jan 15;314:13-16. doi: 10.1016/j.jneuroim.2017.11.011. Epub 2017 Nov 16.

PMID:
29301655
15.

Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika virus infection.

Leonhard SE, Munts AG, van der Eijk AA, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1118-1119. doi: 10.1136/jnnp-2017-317346. Epub 2017 Nov 24. No abstract available.

PMID:
29175895
16.

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study).

Kuitwaard K, Fokkink WR, Brusse E, Vrancken AFJE, Eftimov F, Notermans NC, van der Kooi AJ, Merkies ISJ, Jacobs BC, van Doorn PA.

J Peripher Nerv Syst. 2018 Mar;23(1):5-10. doi: 10.1111/jns.12244. Epub 2017 Nov 21.

PMID:
29119642
17.

Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, van Rossum AMC, Jacobs BC.

J Peripher Nerv Syst. 2018 Mar;23(1):67-69. doi: 10.1111/jns.12243. No abstract available.

PMID:
29119633
18.

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, Fokkink WR, Brusse E, Vrancken AFJE, Eftimov F, Notermans NC, van der Kooi AJ, Merkies ISJ, Jacobs BC, van Doorn PA.

J Peripher Nerv Syst. 2017 Dec;22(4):425-432. doi: 10.1111/jns.12242. Epub 2017 Nov 21. Review.

PMID:
29092099
19.

Prediction of disease progression in Miller Fisher and overlap syndromes.

Verboon C, van Berghem H, van Doorn PA, Ruts L, Jacobs BC.

J Peripher Nerv Syst. 2017 Dec;22(4):446-450. doi: 10.1111/jns.12238. Epub 2017 Nov 15.

PMID:
29065229
20.

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study.

Islam MB, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD.

Pilot Feasibility Stud. 2017 Sep 29;3:40. doi: 10.1186/s40814-017-0185-0. eCollection 2017.

Supplemental Content

Loading ...
Support Center